Correlation Between Zealand Pharma and Ambu AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and Ambu AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and Ambu AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zealand Pharma AS and Ambu AS, you can compare the effects of market volatilities on Zealand Pharma and Ambu AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of Ambu AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and Ambu AS.

Diversification Opportunities for Zealand Pharma and Ambu AS

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Zealand and Ambu is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and Ambu AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambu AS and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with Ambu AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambu AS has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and Ambu AS go up and down completely randomly.

Pair Corralation between Zealand Pharma and Ambu AS

Assuming the 90 days trading horizon Zealand Pharma AS is expected to under-perform the Ambu AS. In addition to that, Zealand Pharma is 2.06 times more volatile than Ambu AS. It trades about -0.05 of its total potential returns per unit of risk. Ambu AS is currently generating about 0.11 per unit of volatility. If you would invest  10,400  in Ambu AS on December 30, 2024 and sell it today you would earn a total of  1,970  from holding Ambu AS or generate 18.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Zealand Pharma AS  vs.  Ambu AS

 Performance 
       Timeline  
Zealand Pharma AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ambu AS 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ambu AS are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental drivers, Ambu AS sustained solid returns over the last few months and may actually be approaching a breakup point.

Zealand Pharma and Ambu AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zealand Pharma and Ambu AS

The main advantage of trading using opposite Zealand Pharma and Ambu AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, Ambu AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambu AS will offset losses from the drop in Ambu AS's long position.
The idea behind Zealand Pharma AS and Ambu AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets